News

BioSpace5d
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
FDA names a new vaccine chief. He is a vocal critic of the agency
The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad to lead the agency’s Center for Biologics Evaluation and ...
RFK Jr. takes aim at COVID shots for kids, worrying vaccine experts
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
The American Journal of Managed Care6d
Biotech Stocks Slide After FDA Selects Prasad to Lead CBER
The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
New FDA Leadership Could Raise The Bar For Drug Approvals
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
Edmonton Journal on MSN4d
Read now: The full text of MHCare's letter to the Alberta government
The following is a letter sent by MHCare to Christopher McPherson, Alberta’s deputy minister for Jobs, Economy and Trade. We ...
The New York Times7d
U.S. and Chinese Officials Will Meet to Talk Trade
The Department of Education announced that it was investigating an upstate New York school district over its policy of letting ... a potential trade deal. Eswar Prasad, a former official at ...
Vinay Prasad, a critic of drug industry and COVID-19 measures, to lead FDA vaccine program
Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...